How do patients with chronic illnesses respond to a public health crisis? Evidence from diabetic patients in Japan during the COVID-19 pandemic
Masataka Harada(Japan University of Economics), Hisatomi Arima(University of Leicester), Naoyuki Nishiya(Iwate Medical University), Takumi Nishi(Fukuoka University), Kozo Tanno(Iwate Medical University), Toshiki Maeda(Fukuoka University)
Cited by 4
Related Papers
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
Genome-wide association study identifies 112 new loci for body mass index in the Japanese population
|Nature Genetics|2017|510
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
|New England Journal of Medicine|2016|437
The Tohoku Medical Megabank Project: Design and Mission
|Journal of Epidemiology|2016|386